RTKN: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
 
m (Bot: HTTP→HTTPS)
Line 1: Line 1:
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{Underlinked|date=June 2016}}
{{PBB_Controls
{{Infobox_gene}}
| update_page = yes
'''Rhotekin''' is a [[protein]] that in humans is encoded by the ''RTKN'' [[gene]].<ref name="pmid9073523">{{cite journal | vauthors = Jang W, Weber JS, Harkins EB, Meisler MH | title = Localization of the rhotekin gene RTKN on the physical maps of mouse chromosome 6 and human chromosome 2p13 and exclusion as a candidate for mnd2 and LGMD2B | journal = Genomics | volume = 40 | issue = 3 | pages = 506–7 |date=May 1997 | pmid = 9073523 | pmc =  | doi = 10.1006/geno.1996.4593 }}</ref><ref name="pmid10940294">{{cite journal | vauthors = Reynaud C, Fabre S, Jalinot P | title = The PDZ protein TIP-1 interacts with the Rho effector rhotekin and is involved in Rho signaling to the serum response element | journal = J Biol Chem | volume = 275 | issue = 43 | pages = 33962–8 |date=Nov 2000 | pmid = 10940294 | pmc =  | doi = 10.1074/jbc.M000465200 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: RTKN rhotekin| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=6242| accessdate = }}</ref>
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
 
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = Rhotekin
| HGNCid = 10466
| Symbol = RTKN
| AltSymbols =;
| OMIM = 602288
| ECnumber =
| Homologene = 7522
  | MGIid = 107371
| Function = {{GNF_GO|id=GO:0000166 |text = nucleotide binding}} {{GNF_GO|id=GO:0005095 |text = GTPase inhibitor activity}} {{GNF_GO|id=GO:0005515 |text = protein binding}} {{GNF_GO|id=GO:0005525 |text = GTP binding}} {{GNF_GO|id=GO:0017049 |text = GTP-Rho binding}}
| Component = {{GNF_GO|id=GO:0005575 |text = cellular_component}} {{GNF_GO|id=GO:0005622 |text = intracellular}}
| Process = {{GNF_GO|id=GO:0006915 |text = apoptosis}} {{GNF_GO|id=GO:0007165 |text = signal transduction}} {{GNF_GO|id=GO:0007266 |text = Rho protein signal transduction}} {{GNF_GO|id=GO:0045767 |text = regulation of anti-apoptosis}}
| Orthologs = {{GNF_Ortholog_box
    | Hs_EntrezGene = 6242
    | Hs_Ensembl = ENSG00000114993
    | Hs_RefseqProtein = NP_001015055
    | Hs_RefseqmRNA = NM_001015055
    | Hs_GenLoc_db =   
    | Hs_GenLoc_chr = 2
    | Hs_GenLoc_start = 74506497
    | Hs_GenLoc_end = 74522568
    | Hs_Uniprot = Q9BST9
    | Mm_EntrezGene = 20166
    | Mm_Ensembl = ENSMUSG00000034930
    | Mm_RefseqmRNA = XM_489714
    | Mm_RefseqProtein = XP_489714
    | Mm_GenLoc_db = 
    | Mm_GenLoc_chr = 6
    | Mm_GenLoc_start = 83101545
    | Mm_GenLoc_end = 83118234
    | Mm_Uniprot = Q8C6B2
  }}
}}
'''Rhotekin''', also known as '''RTKN''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: RTKN rhotekin| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=6242| accessdate = }}</ref>


<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
{{PBB_Summary
| section_title =  
| section_title =  
| summary_text = This gene encodes a scaffold protein that interacts with GTP-bound Rho proteins. Binding of this protein inhibits the GTPase activity of Rho proteins. This protein may interfere with the conversion of active, GTP-bound Rho to the inactive GDP-bound form by RhoGAP. Rho proteins regulate many important cellular processes, including cytokinesis, transcription, smooth muscle contraction, cell growth and transformation. Dysregulation of the Rho signal transduction pathway has been implicated in many forms of cancer. Alternative splicing results in multiple transcript variants encoding different isoforms.<ref name="entrez">{{cite web | title = Entrez Gene: RTKN rhotekin| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=6242| accessdate = }}</ref>
| summary_text = This gene encodes a scaffold protein that interacts with GTP-bound Rho proteins. Binding of this protein inhibits the GTPase activity of Rho proteins. This protein may interfere with the conversion of active, GTP-bound Rho to the inactive GDP-bound form by RhoGAP. Rho proteins regulate many important cellular processes, including cytokinesis, transcription, smooth muscle contraction, cell growth and transformation. Dysregulation of the Rho signal transduction pathway has been implicated in many forms of cancer. Alternative splicing results in multiple transcript variants encoding different isoforms.<ref name="entrez"/>
}}
}}


==References==
==References==
{{reflist|2}}
{{reflist}}
 
==Further reading==
==Further reading==
{{refbegin | 2}}
{{refbegin | 2}}
{{PBB_Further_reading  
{{PBB_Further_reading  
| citations =  
| citations =  
*{{cite journal | author=Reid T, Furuyashiki T, Ishizaki T, ''et al.'' |title=Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain. |journal=J. Biol. Chem. |volume=271 |issue= 23 |pages= 13556-60 |year= 1996 |pmid= 8662891 |doi=  }}
*{{cite journal   |vauthors=Reid T, Furuyashiki T, Ishizaki T, etal |title=Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain. |journal=J. Biol. Chem. |volume=271 |issue= 23 |pages= 13556–60 |year= 1996 |pmid= 8662891 |doi=10.1074/jbc.271.23.13556 }}
*{{cite journal  | author=Jang W, Weber JS, Harkins EB, Meisler MH |title=Localization of the rhotekin gene RTKN on the physical maps of mouse chromosome 6 and human chromosome 2p13 and exclusion as a candidate for mnd2 and LGMD2B. |journal=Genomics |volume=40 |issue= 3 |pages= 506-7 |year= 1997 |pmid= 9073523 |doi= 10.1006/geno.1996.4593 }}
*{{cite journal  |title=Toward a complete human genome sequence. |journal=Genome Res. |volume=8 |issue= 11 |pages= 1097–108 |year= 1999 |pmid= 9847074 |doi= 10.1101/gr.8.11.1097}}
*{{cite journal | author= |title=Toward a complete human genome sequence. |journal=Genome Res. |volume=8 |issue= 11 |pages= 1097-108 |year= 1999 |pmid= 9847074 |doi= }}
*{{cite journal   |vauthors=Fu Q, Yu L, Liu Q, etal |title=Molecular cloning, expression characterization, and mapping of a novel putative inhibitor of rho GTPase activity, RTKN, to D2S145-D2S286. |journal=Genomics |volume=66 |issue= 3 |pages= 328–32 |year= 2000 |pmid= 10873388 |doi= 10.1006/geno.2000.6212 }}
*{{cite journal | author=Fu Q, Yu L, Liu Q, ''et al.'' |title=Molecular cloning, expression characterization, and mapping of a novel putative inhibitor of rho GTPase activity, RTKN, to D2S145-D2S286. |journal=Genomics |volume=66 |issue= 3 |pages= 328-32 |year= 2000 |pmid= 10873388 |doi= 10.1006/geno.2000.6212 }}
*{{cite journal   |vauthors=Strausberg RL, Feingold EA, Grouse LH, etal |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899  | pmc=139241 }}
*{{cite journal | author=Reynaud C, Fabre S, Jalinot P |title=The PDZ protein TIP-1 interacts with the Rho effector rhotekin and is involved in Rho signaling to the serum response element. |journal=J. Biol. Chem. |volume=275 |issue= 43 |pages= 33962-8 |year= 2000 |pmid= 10940294 |doi= 10.1074/jbc.M000465200 }}
*{{cite journal   |vauthors=Sharfe N, Freywald A, Toro A, etal |title=Ephrin stimulation modulates T cell chemotaxis. |journal=Eur. J. Immunol. |volume=32 |issue= 12 |pages= 3745–55 |year= 2003 |pmid= 12516569 |doi= 10.1002/1521-4141(200212)32:12<3745::AID-IMMU3745>3.0.CO;2-M }}
*{{cite journal  | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }}
*{{cite journal  | vauthors=Katoh H, Negishi M |title=RhoG activates Rac1 by direct interaction with the Dock180-binding protein Elmo. |journal=Nature |volume=424 |issue= 6947 |pages= 461–4 |year= 2003 |pmid= 12879077 |doi= 10.1038/nature01817 }}
*{{cite journal | author=Sharfe N, Freywald A, Toro A, ''et al.'' |title=Ephrin stimulation modulates T cell chemotaxis. |journal=Eur. J. Immunol. |volume=32 |issue= 12 |pages= 3745-55 |year= 2003 |pmid= 12516569 |doi= 10.1002/1521-4141(200212)32:12<3745::AID-IMMU3745>3.0.CO;2-M }}
*{{cite journal   |vauthors=Liu CA, Wang MJ, Chi CW, etal |title=Overexpression of rho effector rhotekin confers increased survival in gastric adenocarcinoma. |journal=J. Biomed. Sci. |volume=11 |issue= 5 |pages= 661–70 |year= 2005 |pmid= 15316142 |doi= 10.1159/000079679 }}
*{{cite journal | author=Katoh H, Negishi M |title=RhoG activates Rac1 by direct interaction with the Dock180-binding protein Elmo. |journal=Nature |volume=424 |issue= 6947 |pages= 461-4 |year= 2003 |pmid= 12879077 |doi= 10.1038/nature01817 }}
*{{cite journal   |vauthors=Jacinto E, Loewith R, Schmidt A, etal |title=Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. |journal=Nat. Cell Biol. |volume=6 |issue= 11 |pages= 1122–8 |year= 2004 |pmid= 15467718 |doi= 10.1038/ncb1183 }}
*{{cite journal | author=Liu CA, Wang MJ, Chi CW, ''et al.'' |title=Overexpression of rho effector rhotekin confers increased survival in gastric adenocarcinoma. |journal=J. Biomed. Sci. |volume=11 |issue= 5 |pages= 661-70 |year= 2005 |pmid= 15316142 |doi= 10.1159/000079679 }}
*{{cite journal   |vauthors=Liu CA, Wang MJ, Chi CW, etal |title=Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis. |journal=Oncogene |volume=23 |issue= 54 |pages= 8731–42 |year= 2005 |pmid= 15480428 |doi= 10.1038/sj.onc.1208106 }}
*{{cite journal | author=Jacinto E, Loewith R, Schmidt A, ''et al.'' |title=Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. |journal=Nat. Cell Biol. |volume=6 |issue= 11 |pages= 1122-8 |year= 2004 |pmid= 15467718 |doi= 10.1038/ncb1183 }}
*{{cite journal   |vauthors=Gerhard DS, Wagner L, Feingold EA, etal |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504  | pmc=528928 }}
*{{cite journal | author=Liu CA, Wang MJ, Chi CW, ''et al.'' |title=Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis. |journal=Oncogene |volume=23 |issue= 54 |pages= 8731-42 |year= 2005 |pmid= 15480428 |doi= 10.1038/sj.onc.1208106 }}
*{{cite journal   |vauthors=Fan J, Ma LJ, Xia SJ, etal |title=Association between clinical characteristics and expression abundance of RTKN gene in human bladder carcinoma tissues from Chinese patients. |journal=J. Cancer Res. Clin. Oncol. |volume=131 |issue= 3 |pages= 157–62 |year= 2005 |pmid= 15599595 |doi= 10.1007/s00432-004-0638-8 }}
*{{cite journal | author=Gerhard DS, Wagner L, Feingold EA, ''et al.'' |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121-7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 }}
*{{cite journal   |vauthors=Fernandez-Zapico ME, Gonzalez-Paz NC, Weiss E, etal |title=Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. |journal=Cancer Cell |volume=7 |issue= 1 |pages= 39–49 |year= 2005 |pmid= 15652748 |doi= 10.1016/j.ccr.2004.11.024 }}
*{{cite journal | author=Fan J, Ma LJ, Xia SJ, ''et al.'' |title=Association between clinical characteristics and expression abundance of RTKN gene in human bladder carcinoma tissues from Chinese patients. |journal=J. Cancer Res. Clin. Oncol. |volume=131 |issue= 3 |pages= 157-62 |year= 2005 |pmid= 15599595 |doi= 10.1007/s00432-004-0638-8 }}
*{{cite journal   |vauthors=Park JB, Yiu G, Kaneko S, etal |title=A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. |journal=Neuron |volume=45 |issue= 3 |pages= 345–51 |year= 2005 |pmid= 15694321 |doi= 10.1016/j.neuron.2004.12.040 }}
*{{cite journal | author=Fernandez-Zapico ME, Gonzalez-Paz NC, Weiss E, ''et al.'' |title=Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. |journal=Cancer Cell |volume=7 |issue= 1 |pages= 39-49 |year= 2005 |pmid= 15652748 |doi= 10.1016/j.ccr.2004.11.024 }}
*{{cite journal   |vauthors=Barrios-Rodiles M, Brown KR, Ozdamar B, etal |title=High-throughput mapping of a dynamic signaling network in mammalian cells. |journal=Science |volume=307 |issue= 5715 |pages= 1621–5 |year= 2005 |pmid= 15761153 |doi= 10.1126/science.1105776 }}
*{{cite journal | author=Park JB, Yiu G, Kaneko S, ''et al.'' |title=A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. |journal=Neuron |volume=45 |issue= 3 |pages= 345-51 |year= 2005 |pmid= 15694321 |doi= 10.1016/j.neuron.2004.12.040 }}
*{{cite journal   |vauthors=Satchi-Fainaro R, Mamluk R, Wang L, etal |title=Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. |journal=Cancer Cell |volume=7 |issue= 3 |pages= 251–61 |year= 2005 |pmid= 15766663 |doi= 10.1016/j.ccr.2005.02.007 }}
*{{cite journal | author=Barrios-Rodiles M, Brown KR, Ozdamar B, ''et al.'' |title=High-throughput mapping of a dynamic signaling network in mammalian cells. |journal=Science |volume=307 |issue= 5715 |pages= 1621-5 |year= 2005 |pmid= 15761153 |doi= 10.1126/science.1105776 }}
*{{cite journal   |vauthors=Kukar T, Murphy MP, Eriksen JL, etal |title=Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. |journal=Nat. Med. |volume=11 |issue= 5 |pages= 545–50 |year= 2005 |pmid= 15834426 |doi= 10.1038/nm1235 }}
*{{cite journal  | author=Satchi-Fainaro R, Mamluk R, Wang L, ''et al.'' |title=Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. |journal=Cancer Cell |volume=7 |issue= 3 |pages= 251-61 |year= 2005 |pmid= 15766663 |doi= 10.1016/j.ccr.2005.02.007 }}
*{{cite journal  | vauthors=Kiyan J, Kiyan R, Haller H, Dumler I |title=Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta. |journal=EMBO J. |volume=24 |issue= 10 |pages= 1787–97 |year= 2005 |pmid= 15889147 |doi= 10.1038/sj.emboj.7600669 | pmc=1142599 }}
*{{cite journal | author=Kukar T, Murphy MP, Eriksen JL, ''et al.'' |title=Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. |journal=Nat. Med. |volume=11 |issue= 5 |pages= 545-50 |year= 2005 |pmid= 15834426 |doi= 10.1038/nm1235 }}
*{{cite journal   |vauthors=Ito H, Iwamoto I, Morishita R, etal |title=Possible role of Rho/Rhotekin signaling in mammalian septin organization. |journal=Oncogene |volume=24 |issue= 47 |pages= 7064–72 |year= 2005 |pmid= 16007136 |doi= 10.1038/sj.onc.1208862 }}
*{{cite journal  | author=Kiyan J, Kiyan R, Haller H, Dumler I |title=Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta. |journal=EMBO J. |volume=24 |issue= 10 |pages= 1787-97 |year= 2005 |pmid= 15889147 |doi= 10.1038/sj.emboj.7600669 }}
*{{cite journal | author=Ito H, Iwamoto I, Morishita R, ''et al.'' |title=Possible role of Rho/Rhotekin signaling in mammalian septin organization. |journal=Oncogene |volume=24 |issue= 47 |pages= 7064-72 |year= 2005 |pmid= 16007136 |doi= 10.1038/sj.onc.1208862 }}
}}
}}
{{refend}}
{{refend}}


{{protein-stub}}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{WikiDoc Sources}}
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
 
 
{{gene-2-stub}}

Revision as of 09:33, 10 September 2017

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez

n/a

n/a

Ensembl

n/a

n/a

UniProt

n/a

n/a

RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Rhotekin is a protein that in humans is encoded by the RTKN gene.[1][2][3]

This gene encodes a scaffold protein that interacts with GTP-bound Rho proteins. Binding of this protein inhibits the GTPase activity of Rho proteins. This protein may interfere with the conversion of active, GTP-bound Rho to the inactive GDP-bound form by RhoGAP. Rho proteins regulate many important cellular processes, including cytokinesis, transcription, smooth muscle contraction, cell growth and transformation. Dysregulation of the Rho signal transduction pathway has been implicated in many forms of cancer. Alternative splicing results in multiple transcript variants encoding different isoforms.[3]

References

  1. ↑ Jang W, Weber JS, Harkins EB, Meisler MH (May 1997). "Localization of the rhotekin gene RTKN on the physical maps of mouse chromosome 6 and human chromosome 2p13 and exclusion as a candidate for mnd2 and LGMD2B". Genomics. 40 (3): 506–7. doi:10.1006/geno.1996.4593. PMID 9073523.
  2. ↑ Reynaud C, Fabre S, Jalinot P (Nov 2000). "The PDZ protein TIP-1 interacts with the Rho effector rhotekin and is involved in Rho signaling to the serum response element". J Biol Chem. 275 (43): 33962–8. doi:10.1074/jbc.M000465200. PMID 10940294.
  3. ↑ 3.0 3.1 "Entrez Gene: RTKN rhotekin".

Further reading



Retrieved from "https://www.wikidoc.org/index.php?title=RTKN&oldid=1412240"